tomorrowread
India’s dengue vaccine timeline points to a 2027 rollout through private healthcare
Technology·Medium term·▼ -4%

India’s first dengue vaccine may arrive in 2027, but private pricing could limit who actually gets protected.

A dengue vaccine would be a major public-health milestone for India, but the rollout channel matters as much as the science. If access is mostly private, the people most exposed to outbreaks may not benefit quickly enough.

AI reasoning

A dengue vaccine would be a major public-health milestone for India, but the rollout channel matters as much as the science. If access is mostly private, the people most exposed to outbreaks may not benefit quickly enough.

Curated summary

India may get its first dengue vaccine, Qdenga, in the first half of 2027, likely through private healthcare. Infectious disease expert Chandrakant Lahariya shared the timeline, and Takeda Pharmaceutical had said the same in July. Qdenga is a live, attenuated tetravalent vaccine for ages 4 to 60. The backdrop is severe: WHO recorded 14.4 million dengue cases and 11,201 deaths in 2024, including 232,425 cases and 233 deaths in India.

Supporting evidence

Source news

India’s dengue vaccine timeline points to a 2027 rollout through private healthcare

Qdenga could arrive in the first half of 2027, but pricing and access will decide whether it changes outbreak control or stays niche.

mint - news·1h ago
Read full article at mint - news